These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30289819)

  • 21. Effects of genetic variation in H3K79 methylation regulatory genes on clinical blood pressure and blood pressure response to hydrochlorothiazide.
    Duarte JD; Zineh I; Burkley B; Gong Y; Langaee TY; Turner ST; Chapman AB; Boerwinkle E; Gums JG; Cooper-Dehoff RM; Beitelshees AL; Bailey KR; Fillingim RB; Kone BC; Johnson JA
    J Transl Med; 2012 Mar; 10():56. PubMed ID: 22440088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WNK1 kinase polymorphism and blood pressure response to a thiazide diuretic.
    Turner ST; Schwartz GL; Chapman AB; Boerwinkle E
    Hypertension; 2005 Oct; 46(4):758-65. PubMed ID: 16172412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihypertensive effectiveness of a very low fixed-dose combination of moexipril and hydrochlorothiazide.
    Chrysant SG; Stimpel M
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):384-90. PubMed ID: 9514183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.
    Dahlöf B; Sever PS; Poulter NR; Wedel H; Beevers DG; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J;
    Lancet; 2005 Sep 10-16; 366(9489):895-906. PubMed ID: 16154016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugs.
    Hiltunen TP; Donner KM; Sarin AP; Saarela J; Ripatti S; Chapman AB; Gums JG; Gong Y; Cooper-DeHoff RM; Frau F; Glorioso V; Zaninello R; Salvi E; Glorioso N; Boerwinkle E; Turner ST; Johnson JA; Kontula KK
    J Am Heart Assoc; 2015 Jan; 4(1):e001521. PubMed ID: 25622599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative metabolic effects of hydrochlorothiazide and indapamide in hypertensive diabetic patients receiving ACE inhibitor therapy.
    Krum H; Skiba M; Gilbert RE
    Diabet Med; 2003 Sep; 20(9):708-12. PubMed ID: 12925048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydrochlorothiazide-induced hyperuricaemia in the pharmacogenomic evaluation of antihypertensive responses study.
    Vandell AG; McDonough CW; Gong Y; Langaee TY; Lucas AM; Chapman AB; Gums JG; Beitelshees AL; Bailey KR; Johnson RJ; Boerwinkle E; Turner ST; Cooper-DeHoff RM; Johnson JA
    J Intern Med; 2014 Nov; 276(5):486-97. PubMed ID: 24612202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study Investigators.
    Oparil S; Levine JH; Zuschke CA; Gradman AH; Ripley E; Jones DW; Hardison JD; Cushing DJ; Prasad R; Michelson EL
    Am J Cardiol; 1999 Aug; 84(3):289-93. PubMed ID: 10496437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy and safety of combination therapy with losartan and hydrochlorothiazide in elderly hypertension].
    Eto K; Tsuchihashi T; Abe I; Iida M
    Nihon Ronen Igakkai Zasshi; 2002 Mar; 39(2):181-6. PubMed ID: 11974942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patients.
    Lobmeyer MT; Wang L; Zineh I; Turner ST; Gums JG; Chapman AB; Cooper-DeHoff RM; Beitelshees AL; Bailey KR; Boerwinkle E; Pepine CJ; Johnson JA
    Pharmacogenet Genomics; 2011 Jan; 21(1):42-9. PubMed ID: 21127457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interacting effects of gender and genotype on blood pressure response to hydrochlorothiazide.
    Schwartz GL; Turner ST; Chapman AB; Boerwinkle E
    Kidney Int; 2002 Nov; 62(5):1718-23. PubMed ID: 12371972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treating essential hypertension. The first choice is usually a thiazide diuretic.
    Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of hypertension: the role of combination therapy.
    Plat F; Saini R
    Am J Hypertens; 1997 Oct; 10(10 Pt 2):262S-271S. PubMed ID: 9366283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The long-term antihypertensive activity and tolerability of irbesartan with hydrochlorothiazide.
    Raskin P; Guthrie R; Flack J; Reeves R; Saini R
    J Hum Hypertens; 1999 Oct; 13(10):683-7. PubMed ID: 10516738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic and Cardiovascular Effects of Switching Thiazides to Amlodipine in Hypertensive Patients With and Without Type 2 Diabetes (the Diuretics and Diabetes Control Study).
    Buscemi S; Buscemi C; Borzì AM; Cosentino L; Rosafio G; Randazzo C; Colomba D; Di Raimondo D; Pluchinotta FR; Parrinello G
    Metab Syndr Relat Disord; 2020 Mar; 18(2):110-118. PubMed ID: 31976814
    [No Abstract]   [Full Text] [Related]  

  • 36. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
    Breithaupt-Grögler K; Gerhardt G; Lehmann G; Notter T; Belz GG
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):425-31. PubMed ID: 9726695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension.
    Vandell AG; Lobmeyer MT; Gawronski BE; Langaee TY; Gong Y; Gums JG; Beitelshees AL; Turner ST; Chapman AB; Cooper-DeHoff RM; Bailey KR; Boerwinkle E; Pepine CJ; Liggett SB; Johnson JA
    Hypertension; 2012 Oct; 60(4):957-64. PubMed ID: 22949529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study.
    Freytag F; Schelling A; Meinicke T; Deichsel G;
    Clin Ther; 2001 Jan; 23(1):108-23. PubMed ID: 11219471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing.
    Pelttari LH; Hietanen EK; Salo TT; Kataja MJ; Kantola IM
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):272-9. PubMed ID: 9544866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrochlorothiazide vs chlorthalidone, indapamide, and potassium-sparing/hydrochlorothiazide diuretics for reducing left ventricular hypertrophy: A systematic review and meta-analysis.
    Roush GC; Abdelfattah R; Song S; Ernst ME; Sica DA; Kostis JB
    J Clin Hypertens (Greenwich); 2018 Oct; 20(10):1507-1515. PubMed ID: 30251403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.